Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Pain 23Neoplasms 19Cancer Pain 9Colonic Neoplasms 7Breakthrough Pain 7Agnosia 7Breast Neoplasms 5Rectal Neoplasms 4Prostatic Neoplasms 4Lung Neoplasms 4Head and Neck Neoplasms 4Chronic Pain 4Urinary Bladder Neoplasms 3Pancreatic Neoplasms 3Pain, Postoperative 3Sarcoma 2Pleural Effusion, Malignant 2Lymphoma, Follicular 2Diverticulosis, Colonic 2Carcinoma, Hepatocellular 2Burns 2Brain Neoplasms 2Anemia, Sickle Cell 2post laminectomy syndrome 1Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Vipoma 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Urethral Neoplasms 1

Interventions

Sevoflurane 1Propofol 1Melatonin 1Fentanyl 1Atracurium 1Antineoplastic Agents, Hormonal 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Female Breast Cancer × Fentanyl × Clear all
NCT03005860 2023-12-21

Effect of TIVA Propofol vs Sevoflurane Anaesthetic on Serum Biomarkers and on PBMCs in Breast Cancer Surgery

Tata Memorial Centre

Phase NA Withdrawn
Breast

Female Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡